Clin2
NCT06319248Possibly a fitRecruiting

Midodrine to treat sepsis and reduce IV vasopressors

SepsisLow Blood Pressure

Treatments studied

Part of Heart & circulation, Infections clinical trials.

This trial tests if the oral medication midodrine can help wean patients with sepsis off IV vasopressors faster, potentially reducing ICU stays and complications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
308 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Diagnosed with sepsis within the last 24 hours
  • Need IV medication to keep blood pressure up or have low blood pressure after fluids
  • Not on very high doses of IV vasopressors
  • No serious heart, liver, or bowel problems
  • Not pregnant, no recent stroke or heart attack

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07343206Recruiting
Early norepinephrine for sepsis with low blood pressure

This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.

Bangkok Noi, Bangkok
NCT05179499Recruiting· Phase 3
Early norepinephrine for low blood pressure in sepsis

This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.

Aintree
NCT07657702Not yet recruiting
Studying anisodamine for improving blood flow during septic shock

This study tests a medication called anisodamine to see if it can improve blood flow in tiny blood vessels under the tongue in people with septic shock. This might help their organs work better and make them recover faster.

Wuhu, Anhui
NCT05634057Recruiting
Treating sepsis with a medication plus blood thinner

This trial studies whether combining anisodamine (a medicine for certain gut/smooth-muscle effects) with a low-molecular-weight blood thinner helps treat sepsis. It may be aimed at improving outcomes compared with standard care, but eligibility depends on safety factors like bleeding risk and organ function.

Beijing, China
NCT05882708Recruiting· Phase 4
Ivabradine to slow heart rate in sepsis ICU patients

This study tests whether ivabradine (a heart-rate medicine) can improve blood flow and other vital measurements in adults with sepsis in the ICU. It may help by lowering a fast heart rate when blood pressure is already being supported.

Guangzhou, Guangdong
NCT07869693Not yet recruiting
Norepinephrine before anesthesia for sepsis patients having surgery

This trial tests whether giving a medicine called norepinephrine before anesthesia can help stabilize blood pressure in patients with sepsis who are having surgery. It aims to reduce complications during and after the operation.

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.